Posted On: 08/24/2014 7:09:44 PM
Post# of 30038
Re: MikeChavelle #4694
Quote:
"We expect significant announcements to begin regarding our mid-clinical stage therapeutic program Eltoprazine, including the initiation of our 200 patient Phase 2b clinical trial for Parkinson’s disease Levadopa-Induced Dyskinesia (PD-LID)"
See more at:
http://www.thechairmansblog.com/amarantus-bio...iqU0s.dpuf
(0)
(0)Scroll down for more posts ▼
